Tarsus Pharmaceuticals logo

Tarsus Pharmaceuticals Share Price Today

(NASDAQ: TARS)

Tarsus Pharmaceuticals share price is $52.23 & ₹4,536.44 as on 14 Feb 2025, 2.30 'hrs' IST

$52.23

-0.1

(-0.19%)

Market is closed - opens 8 PM, 14 Feb 2025

View live Tarsus Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Tarsus Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tarsus Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Tarsus Pharmaceuticals share price movements

  • Today's Low: $51.10
    Today's High: $53.00

    Day's Volatility :3.59%

  • 52 Weeks Low: $20.08
    52 Weeks High: $57.28

    52 Weeks Volatility :64.94%

Tarsus Pharmaceuticals (TARS) Returns

PeriodTarsus Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
16.51%
1.3%
0.0%
6 Months
103.31%
-3.5%
0.0%
1 Year
65.55%
1.6%
0.0%
3 Years
226.44%
13.6%
-12.5%

Tarsus Pharmaceuticals (TARS) Key Statistics

in dollars & INR

Previous Close
$52.33
Open
$52.75
Today's High
$53.0
Today's Low
$51.095
Market Capitalization
$2.0B
Today's Volume
$434.9K
52 Week High
$57.28
52 Week Low
$20.0818
Revenue TTM
$129.6M
EBITDA
$-139.5M
Earnings Per Share (EPS)
$-3.75
Profit Margin
-103.64%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-59.56%

How to invest in Tarsus Pharmaceuticals Stock (TARS) from India?

It is very easy for Indian residents to invest directly in Tarsus Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tarsus Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tarsus Pharmaceuticals or TARS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tarsus Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tarsus Pharmaceuticals shares which would translate to 0.017 fractional shares of Tarsus Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Tarsus Pharmaceuticals, in just a few clicks!

Returns in Tarsus Pharmaceuticals (TARS) for Indian investors in Rupees

The Tarsus Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tarsus Pharmaceuticals investment value today

Current value as on today

₹1,70,158

Returns

₹70,158

(+70.16%)

Returns from Tarsus Pharmaceuticals Stock

₹65,547 (+65.55%)

Dollar Returns

₹4,611 (+4.61%)

Indian investors sentiment towards Tarsus Pharmaceuticals (TARS)

-50%

Period: Jan 14, 2025 to Feb 13, 2025. Change in 30 Days versus previous period

Search interest for Tarsus Pharmaceuticals Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Tarsus Pharmaceuticals

  • BlackRock Inc

    9.82%

  • RTW INVESTMENTS, LLC

    8.93%

  • Jennison Associates LLC

    6.54%

  • Paradigm Biocapital Advisors LP

    6.38%

  • TANG CAPITAL MANAGEMENT LLC

    5.90%

  • Morgan Stanley - Brokerage Accounts

    5.78%

Analyst Recommendation on Tarsus Pharmaceuticals

Buy

    86%Buy

    13%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Tarsus Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
13
13
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Tarsus Pharmaceuticals Stock (TARS)

What analysts predicted

Upside of 29.34%

Target:

$67.56

Current:

$52.23

Insights on Tarsus Pharmaceuticals Stock (Ticker Symbol: TARS)

  • Price Movement

    In the last 6 months, TARS stock has moved up by 95.9%

Tarsus Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Tarsus Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Tarsus Pharmaceuticals (TARS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tarsus Pharmaceuticals Inc logo
12.18%
103.31%
65.55%
226.44%
153.79%
Biontech Se logo
8.01%
44.12%
32.15%
-24.88%
289.28%
Regeneron Pharmaceuticals, Inc. logo
-4.15%
-42.83%
-29.38%
7.0%
69.56%
Vertex Pharmaceuticals Incorporated logo
9.03%
-3.1%
8.51%
98.18%
88.09%
Alnylam Pharmaceuticals, Inc. logo
5.53%
-1.25%
79.67%
72.79%
105.85%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tarsus Pharmaceuticals Inc logo
NA
NA
NA
-3.27
-0.6
-0.27
NA
6.22
Biontech Se logo
160.8
NA
0.04
-3.29
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
17.32
17.32
0.98
43.2
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.19
18.18
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tarsus Pharmaceuticals Inc logo
Buy
$2.0B
153.79%
NA
-103.64%
Biontech Se logo
Buy
$27.5B
289.28%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$72.6B
69.56%
17.32
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$116.9B
88.09%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$34.3B
105.85%
NA
-15.86%

About Tarsus Pharmaceuticals

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Organization
Tarsus Pharmaceuticals
Employees
244
CEO
Dr. Bobak R. Azamian M.D.
Industry
Health Technology

Management People of Tarsus Pharmaceuticals

NameTitle
Dr. Bobak R. Azamian M.D.
Co-Founder, President, CEO & Chairman
Mr. Jeffrey S. Farrow CPA
CFO & Chief Strategy Officer
Dr. Seshadri Neervannan Ph.D.
Chief Operating Officer
Dr. Elizabeth Yeu M.D.
Chief Medical Officer
Mr. David Nakasone
Head of Investor Relations
Dr. Bryan Wahl J.D., M.D.
General Counsel & Corporate Secretary
Ms. Adrienne Kemp
Senior Director of Corporate Communications
Mr. Matthew Rossen M.B.A.
Vice President of Marketing
Mr. Scott Youmans
Vice President of Sales
Ms. Dianne C. Whitfield M.S.W.
Chief Human Resources Officer

Important FAQs about investing in TARS Stock from India :

What is Tarsus Pharmaceuticals share price today?

Tarsus Pharmaceuticals share price today stands at $52.23, Open: $52.75 ; Previous Close: $52.33 ; High: $53.00 ; Low: $51.10 ; 52 Week High: $57.28 ; 52 Week Low: $20.08.

The stock opens at $52.75, after a previous close of $52.33. The stock reached a daily high of $53.00 and a low of $51.10, with a 52-week high of $57.28 and a 52-week low of $20.08.

Can Indians buy Tarsus Pharmaceuticals shares?

Yes, Indians can invest in the Tarsus Pharmaceuticals (TARS) from India.

With INDmoney, you can buy Tarsus Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Tarsus Pharmaceuticals at zero transaction cost.

How can I buy Tarsus Pharmaceuticals shares from India?

It is very easy to buy Tarsus Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tarsus Pharmaceuticals (TARS) be purchased?

Yes, you can buy fractional shares of Tarsus Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Tarsus Pharmaceuticals stocks?

To start investing in Tarsus Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Tarsus Pharmaceuticals Stock (TARS)?

Today’s highest price of Tarsus Pharmaceuticals (TARS) is $53.00.

Today’s lowest price of Tarsus Pharmaceuticals (TARS) is $51.10.

What is today's market capitalisation of Tarsus Pharmaceuticals?

Today's market capitalisation of Tarsus Pharmaceuticals TARS is 2.0B

What is the 52 Week High and Low Range of Tarsus Pharmaceuticals Stock (TARS)?

  • 52 Week High

    $57.28

  • 52 Week Low

    $20.08

What are the historical returns of Tarsus Pharmaceuticals (TARS)?

  • 1 Month Returns

    12.18%

  • 3 Months Returns

    103.31%

  • 1 Year Returns

    65.55%

  • 5 Years Returns

    153.79%

Who is the Chief Executive Officer (CEO) of Tarsus Pharmaceuticals ?

Dr. Bobak R. Azamian M.D. is the current Chief Executive Officer (CEO) of Tarsus Pharmaceuticals.